Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2014 > Volume 23 Number 6 November 2014 > MITRAL VALVE DISEASE > Asymmetric Ring Annuloplasty for Ischemic Mitral Regurgitation: Early and Mid-Term Outcomes

Asymmetric Ring Annuloplasty for Ischemic Mitral Regurgitation: Early and Mid-Term Outcomes

Giuseppe Gatti1, Luca Dell’Angela2, Bruno Pinamonti2, Livio Gon1, Bernardo Benussi1, Gianfranco Sinagra2, Aniello Pappalardo1

Divisions of 1Cardiac Surgery and 2Cardiology, Ospedali Riuniti, Trieste, Italy

Background and aim of the study: The Carpentier-McCarthy-Adams IMR ETlogix® annuloplasty ring was specifically designed to treat ischemic mitral regurgitation (IMR) associated with asymmetric mitral annular dilation and leaflet tethering. The study aim was to review, retrospectively, the results of mitral annuloplasty with this asymmetric ring in a representative number of patients.

Methods: Between January 2005 and July 2012, the IMR ETlogix ring was implanted in 190 consecutive patients (mean age 69.5 ± 7.6 years) with grade ≥2+ IMR (graded from 0 to 3+). Preoperatively, 37 patients (19.5%) were in NYHA class IV, and 73 (38.4%) suffered from unstable angina. The operative risk according to the European System for Cardiac Operative Risk Evaluation II was 15.6 ± 14.5%. Using two-dimensional echocardiography, postoperative changes in mitral annular diameter (MAD) and tenting height (TH) of the mitral valve in four-chamber, two-chamber and long-axis views, were assessed at mid-systole.

Results: Thirty-eight patients (20.0%) received one or more concomitant major cardiac surgical procedure(s) other than,

or in addition to, coronary artery bypass grafting or tricuspid valve annuloplasty. Nineteen (10.0%) hospital deaths occurred, and one patient underwent immediate reoperation for residual MR. During the follow up (mean 4.8 ± 2.1 years) there were 26 cardiac deaths, 14 non-cardiac deaths, and three mitral valve replacements. The seven-year actuarial survival, freedom from grade ≥2+ MR and reoperation were 62.0%, 93.1% and 97.6%, respectively. Renal impairment (p = 0.012) and extracardiac arteriopathy (p = 0.047) were predictors of death; bilateral internal thoracic artery grafting was a protective factor (p = 0.033). Heart failure symptoms were improved (p <0.01). Left ventricular reverse remodeling was achieved in 50.6% of patients. The MAD and TH were each decreased in all three echocardiographic views (p <0.001), the reductions being greater in the long-axis view.

Conclusion: By restoring the mitral apparatus geometry and competence, asymmetric annuloplasty with the IMR ETlogix ring provides good mid-term outcomes and helps left ventricular reverse remodeling in IMR.

The Journal of Heart Valve Disease 2014;23:695-706


Asymmetric Ring Annuloplasty for Ischemic Mitral Regurgitation: Early and Mid-Term Outcomes

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.